Biggest News Aggregation in the World
📰 Allarity News

Allarity News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allarity. Real-time updates on events, politics, business and more.

Allarity Therapeutics, Inc.: This Combination Therapy Could Help Change Cancer Treatment - Take A Deeper Look Into Allarity Therapeutics' Trial

CAMBRIDGE, MA / ACCESSWIRE / April 17, 2023 / Allarity Therapeutics (NASDAQ:ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drugs, stenoparib and
United Kingdom Mansoor Raza Mirza Kathleenn Moore Allarity Therapeuticsview Thomas Pedersen Thomas Jensen

EQS-News: Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform

EQS-News: Allarity Therapeutics, Inc. Precision Medicine Could Get Even More Precise With Allarity Therapeutics’ “Next-Generation” Diagnostics Platform 18.10.2022 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Once brought into its pipeline, Allarity uses...
United States Foundationfocus Cdx Thomas Pedersen Foundation Medicine Inc Drug Administration Eisai Co

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Allarity Therapeutics, Inc.: Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Cambridge, MA U.S.A. (April 22, 2022) - Allarity Therapeutics, Inc. (Nasdaq: ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together
United Kingdom Thomas Pedersen Chuck Padala Jens Knudsen Carrotize Pr Communications Company Contact

Allarity Therapeutics A/S: Allarity Therapeutics Presents Dovitinib Survival Data from DRP Screened RCC Patients at ESMO 2021 Virtual Congress

Patient selection using DRP score of 50% resulted in a median survival of 15.0 monthPatient selection using DRP score of 67% resulted in a median survival of 20.6 months Press Release Hørsholm
Steve Carchedi Thomas Pedersen Mike Beyer Carrotize Pr Communications Drug Administration Sam Brown Inc

Allarity Therapeutics A/S : Announces Extraordinary Exercise Period for Warrants of Series ALLR TO 3 Set to August 30 – September 13, 2021

Press Release Hørsholm, Denmark – Allarity Therapeutics A/S today announces that an accelerated extraordinary and final exercise period for warrants of the ALLR TO 3 series , which... | August 27, 2021
New York United States Mazanti Andersen Advokatpartnerselskab Thomas Pedersen Hagberg Aneborn Fondkommission Important Information About The Recapitalization Share Exchange

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science